The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Mechanisms of melanocyte death in vitiligo
Open accessAbstract
Vitiligo is an autoimmune depigment disease results from extensive melanocytes destruction. The destruction of melanocyte is thought to be of multifactorial causation. Genome‐wide associated studies have identified single‐nucleotide polymorphisms in a panel of susceptible loci as risk factors in melanocyte death. But vitiligo onset can't be solely attributed to a susceptive genetic background. Oxidative stress triggered by elevated levels of reactive oxygen species accounts for melanocytic molecular and organelle dysfunction, a minority of melanocyte demise, and melanocyte‐specific antigens exposure. Of note, the self‐responsive immune function directly contributes to the bulk of melanocyte deaths in vitiligo. The aberrantly heightened innate immunity, type‐1‐skewed T helper, and incompetent regulatory T cells tip the balance toward autoreaction and CD8+ cytotoxic T lymphocytes finally execute the killing of melanocytes, possibly alarmed by resident memory T cells. In addition to the well‐established apoptosis and necrosis, we discuss several death modalities like oxeiptosis, ferroptosis, and necroptosis that are probably employed in melanocyte destruction. This review focuses on the various mechanisms of melanocytic death in vitiligo pathogenesis to demonstrate a panorama of that. We hope to provide new insights into vitiligo pathogenesis and treatment strategies by the review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–231 of 231
Jiang, W. M., Li, S., Chen, X., Zhang, W., Chang, Y., He, Y., Zhang, S., Su, X., Gao, T., Li, C., et al. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.03.007 · Cited by 48
Self-citationZhang, S., Yi, X., Su, X., Jian, Z., Cui, T., Guo, S., Gao, T., Li, C., Li, S., & Xiao, Q. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14393 · Cited by 47
Self-citationJimbo, H., Nagai, H., Fujiwara, S., Shimoura, N., & Nishigori, C. (2019) · Experimental Dermatology · doi:10.1111/exd.14053 · Cited by 47
Magee, C. N., Murakami, N., Borges, T. J., Shimizu, T., Safa, K., Ohori, S., Cai, S., Uffing, A., Azzi, J. R., Elyaman, W., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040563 · Cited by 46
Immune-modifying properties of topical vitamin D: Focus on dendritic cells and T cells
Gorman, S., Judge, M. A., & Hart, P. H. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.034 · Cited by 43
Boniface, K., & Sénéschal, J. (2019) · Experimental Dermatology · doi:10.1111/exd.13879 · Cited by 43
Mou, K., Pan, W., Han, D., Wen, X., Cao, F., Miao, Y., & Li, P. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4200 · Cited by 43
Ostankovitch, M., Robila, V., & Engelhard, V. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2544 · Cited by 42
Oxidation products are increased in patients affected by non-segmental generalized vitiligo
Vaccaro, M., Bagnato, G., Cristani, M., Borgia, F., Spatari, G., Tigano, V., Saja, A., Guarneri, F., Cannavò, S. P., & Gangemi, S. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-017-1746-z · Cited by 40
Mansuri, M. S., Jadeja, S. D., Singh, M., Laddha, N. C., Dwivedi, M., & Begum, R. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15681 · Cited by 37
Sharaf, M. S., Stevens, D., & Kamunde, C. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.06.005 · Cited by 37
Skin‐resident memory T cells as a potential new therapeutic target in vitiligo and melanoma
Willemsen, M., Linkutė, R., Luiten, R. M., & Matos, T. R. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12803 · Cited by 37
Regulatory T cells in autoimmune skin diseases
Ujiie, H. (2018) · Experimental Dermatology · doi:10.1111/exd.13535 · Cited by 36
Regulatory T‐cell cytokines in patients with nonsegmental vitiligo
Kıdır, M., Karabulut, A. A., Erçin, M. E., & Atasoy, P. (2017) · International Journal of Dermatology · doi:10.1111/ijd.13564 · Cited by 34
Unconventional Treatments for Vitiligo: Are They (Un) Satisfactory?
Gianfaldoni, S., Tchernev, G., Lotti, J., Wollina, U., Satolli, F., Rovesti, M., França, K., & Lotti, T. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.038 · Cited by 34
Rahimi, A. R., Hossein‐Nataj, H., Hajheydari, Z., Aryanian, Z., Shayannia, A., Ajami, A., & Asgarian‐Omran, H. (2019) · Experimental Dermatology · doi:10.1111/exd.13952 · Cited by 31
Li, M., Sun, D., Li, C., Zhang, Z., Gao, L., Li, K., Li, H., & Gao, T. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.161 · Cited by 30
Self-citationJung, E., Kim, J. H., Kim, M., Lee, S. Y., & Lee, J. (2016) · Experimental Dermatology · doi:10.1111/exd.13277 · Cited by 30
Tsuji, G., Hashimoto‐Hachiya, A., Takemura, M., Kanemaru, T., Ichihashi, M., & Furue, M. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.02.981 · Cited by 30
Sastry, K. S., Naeem, H., Mokrab, Y., & Chouchane, A. I. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2841814 · Cited by 30
Terras, S., Gambichler, T., Moritz, R. K. C., Altmeyer, P. J., & Lambert, J. (2013) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2012.05808.x · Cited by 28
Jin, Y., Andersen, G. H. L., Santorico, S. A., & Spritz, R. A. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.021 · Cited by 28
Bellei, B., Papaccio, F., Filoni, A., Caputo, S., Lopez, G., Migliano, E., & Picardo, M. (2019) · Experimental Dermatology · doi:10.1111/exd.13954 · Cited by 26
Homocysteine induces melanocytes apoptosis via PERK–eIF2α–CHOP pathway in vitiligo
Chen, J., Zhuang, T., Chen, J., Tian, Y., Yi, X., Ni, Q., Zhang, W., Song, P., Jian, Z., Liu, L., et al. (2020) · Clinical Science · doi:10.1042/cs20200218 · Cited by 24
Self-citationKim, H., Park, C. S., & Lee, A. (2017) · Environmental Toxicology · doi:10.1002/tox.22461 · Cited by 20
Toh, J. J. H., Bhoi, S., Tan, V. W. D., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16563 · Cited by 14
Contradictory effects of chemical filters in UV/ROS-stressed human keratinocyte and fibroblast cells
Hofer, S., Stonig, M., Wally, V., Hartmann, A., Fuchs, D., Hermann, M., Paparella, M., Ganzera, M., & Gostner, J. M. (2018) · ALTEX · doi:10.14573/altex.1808201 · Cited by 14
Homan, M. W. L., Wolkerstorfer, A., Sprangers, M. A. G., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04568.x · Cited by 11
A pilot study to determine vitiligo target size using a computer-based image analysis program
Sheth, V. M., Rithe, R., Pandya, A. G., & Chandrakasan, A. P. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.04.035 · Cited by 10
Malhotra, A. G., Singh, S., Jha, M., & Pandey, K. M. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2835459 · Cited by 9
Clinimetric analysis of recently applied quantitative tools in evaluation of vitiligo treatment
Salem, R., Mikhael, N., Sabry, H. H., El-Refaey, A., El-Gendy, M. F., & Farid, S. A. (2019) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/ijdvl.ijdvl_63_17 · Cited by 9
Cited by
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
Rosmarin, D., Passeron, T., Pandya, A. G., Grimes, P., Harris, J. E., Desai, S. R., Lebwohl, M., Ruer-Mulard, M., Seneschal, J., Wolkerstorfer, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118828 · Cited by 316
Baicalein inhibits RLS3-induced ferroptosis in melanocytes
Yang, M., Li, X., Li, H., Zhang, X., Liu, X., & Song, Y. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.05.010 · Cited by 53
Metadata
- Authors
- Chen, J., Li, S., & Li, C.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2020-11-17
- Volume
- 41
- Issue
- 2
- Pages
- 1138-1166
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W3100014595
- Cited by
- 307
- References
- 231
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.